Palisade Bio, Inc.
PALI· Nasdaq
PALIPalisade Bio, Inc.
Released Aug 15, 2022, during market hours
10-Q filed Aug 15, 2022, 46 days after period end · 0000950170-22-017248
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2022 | Q2 2021 | Q2 2020 | Q2 2019 |
|---|---|---|---|---|
| Revenue | $0.00 | — | $2.50K | $7.89K |
| Net Income | -$2.34M | -$31.75M | -$1.85M | -$1.44M |
| EPS Diluted | -$5.77 |
Palisade Bio, Inc. · CIK 1357459 · Engraved from SEC EDGAR
| -$4.10 |
| -$0.67 |
| -$1.45 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
